China and India Manufacturing: Risks and FDA Monitoring in Pharmaceutical Supply Chains
China and India dominate global pharmaceutical manufacturing, but their regulatory risks and FDA monitoring differ sharply. India leads in compliance and FDA approvals, while China offers scale - but with higher contamination risks. Understanding this divide is key to drug safety.